| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2022―Dec―01 |
Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study |
Mayra Cristina da Luz Pádua Guimarães, Juliana Chaves Coelho, Juliano dos Santos, Camila Braga de Oliveira Higa, Carime Farah Flórido, Renata Jae Won Lee, et al. (+4) Grazielli Soares Paes, Giovanio Vieira da Silva, Luciano Ferreira Drager, Angela Maria Geraldo Pierin |
| 2 |
[GO] |
2022―Jul―15 |
Self-care of hypertension of older adults during COVID-19 lockdown period: a randomized controlled trial |
Khitam Alsaqer, Hatice Bebis |
| 3 |
[GO] |
2021―Jun―01 |
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19 |
Si-Hyuck Kang, Dong-Hoon Lee, Kyung-Do Han, Jin-Hyung Jung, Sang-Hyun Park, Andrew M. Dai, et al. (+5) Henry G. Wei, Chang-Hwan Yoon, Tae-Jin Youn, In-Ho Chae, Cheol-Ho Kim |
| 4 |
[GO] |
2021―Jan―15 |
Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)? |
Ramin Hosseinzadeh, Mohammad Ali Sheikh Beig Goharrizi, Mansour Bahardoust, Akbar Ghorbani Alvanegh, Mohammad Reza Ataee, Mehdi Bagheri, et al. (+3) Ensiyeh Shabani Navidiyan, Seyed Reza Hosseini Zijoud, Mohammad Heiat |
| 5 |
[GO] |
2020―Jul―15 |
The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms |
Craig Steven McLachlan |
| 6 |
[GO] |
2020―May―07 |
Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic? |
Sungha Park, Hae Young Lee, Eun Joo Cho, Ki Chul Sung, Juhan Kim, Dae-Hee Kim, et al. (+8) Sang-Hyun Ihm, Kwang-il Kim, Il-Suk Sohn, Wook-Jin Chung, Hyeon Chang Kim, Sung Kee Ryu, Wook Bum Pyun, Jinho Shin |
|
